Глава 2. Розацеа

Serarslan G., Makbule Kaya Ö., Dirican E. Scale and pustule on dermoscopy of rosacea: a diagnostic clue for demodex species // Dermatol. Pract. Concept. 2021. Vol. 11. N. 1. Article ID e2021139. DOI: https://doi.org/10.5826/dpc.1101a139. PMID: 33614217; PMCID: PMC7875658.

Shi H., Zhang E., Zhang M., Lin T. Narrow-band intense pulsed light as treatment for erythematotelangiectatic rosacea: a retrospective study // J. Drugs Dermatol. 2023. Vol. 22. N. 11. P. 1095–1098. DOI: https://doi.org/10.36849/JDD.4920. PMID: 37943269.

Siddiqui K., Stein Gold L., Gill J. The efficacy, safety, and tolerability of ivermectin compared with current topical treatments for the inflammatory lesions of rosacea: a network meta-analysis // Springerplus. 2016. Vol. 5. N 1. P. 1151. DOI: https://doi.org/10.1186/s40064-016-2819-8. PMID: 27504249; PMCID: PMC4956638.

Simental-Lara F., Ponce-Olivera R.M. Rosácea fulminante asociada con colitis ulcerativa. Caso clinico // Dermatol. Rev. Mex. 2014. Vol. 58. P. 471–475.

Smith K.W. Perioral dermatitis with histopathologic features of granulomatous rosacea: successful treatment with isotretinoin // Cutis. 1990. Vol. 46. N. 5. P. 413–415. PMID: 2148143.

Smith L.A., Meehan S.A., Cohen D.E. Rosacea fulminans with extrafacial lesions in an elderly man: successful treatment with subantimicrobial-dose doxycycline // J. Drugs Dermatol. 2014. Vol. 13. N. 6. P. 763–765. PMID: 24918570.

Smith M., Wolffsohn J.S., Chiang J.C.B. Topical ivermectin 1.0% cream in the treatment of ocular demodicosis // Cont. Lens. Anterior Eye. 2024. Vol. 47. N. 1. Article ID 102099. DOI: https://doi.org/10.1016/j.clae.2023.102099. Epub 2023 Dec 3. PMID: 38049351.

Snapp R.H. Lewandowsky’s rosacea-like eruption; a clinical study // J. Invest. Dermatol. 1949. Vol. 13. N. 4. P. 175–190. DOI: https://doi.org/10.1038/jid.1949.86. PMID: 15391319.

Sobolewska B., Doycheva D., Deuter C.M. et al. Efficacy of topical ivermectin for the treatment of cutaneous and ocular rosacea // Ocul. Immunol. Inflamm. 2021. Vol. 29. N. 6. P. 1137–1141. DOI: https://doi.org/10.1080/09273948.2020.1727531. Epub 2020 Apr 7. PMID: 32255398.

Stein Gold L., Kircik L., Fowler J. et al.; Ivermectin Phase 3 Study Group. Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials // J. Drugs Dermatol. 2014. Vol. 13. N. 11. P. 1380–1386. PMID: 25607706.

Stein L., Kircik L., Fowler J. et al. Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies // J. Drugs Dermatol. 2014. Vol. 13. N. 3. P. 316–323.

Taieb A., Ortonne J.P., Ruzicka T. et al.; Ivermectin Phase III Study Group. Superiority of ivermectin 1% cream over metronidazole 0·75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial // Br. J. Dermatol. 2015. Vol. 172. N. 4. P. 1103–1110. DOI: https://doi.org/10.1111/bjd.13408. Epub 2015 Feb 11. PMID: 25228137.

Tan J., Almeida L.M., Bewley A. et al. Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel // Br. J. Dermatol. 2017. Vol. 176. N. 2. P. 431–438. DOI: https://doi.org/10.1111/bjd.15122. Epub 2017 Jan 23. PMID: 27718519.

Tan J., Schöfer H., Araviiskaia E. et al.; RISE Study Group. Prevalence of rosacea in the general population of Germany and Russia — the RISE study // J. Eur. Acad. Dermatol. Venereol. 2016. Vol. 30. N. 3. P. 428–434. DOI: https://doi.org/10.1111/jdv.13556. PMID: 26915718; PMCID: PMC5067643.

Tan J., Steinhoff M., Berg M. et al.; Rosacea International Study Group. Shortcomings in rosacea diagnosis and classification // Br. J. Dermatol. 2017. Vol. 176. N. 1. P. 197–199. DOI: https://doi.org/10.1111/bjd.14819. PMID: 28098383.

Thibaut de Ménonville S., Rosignoli C., Soares E. et al. Topical treatment of rosacea with ivermectin inhibits gene expression of cathelicidin innate immune mediators, LL-37 and KLK5, in reconstructed and ex vivo skin models // Dermatol. Ther. (Heidelb.). 2017. Vol. 7. N. 2. P. 213–225. DOI: https://doi.org/10.1007/s13555-017-0176-3. Epub 2017 Feb 27. PMID: 28243927; PMCID: PMC5453918.

Thiboutot D., Anderson R., Cook-Bolden F. et al. Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee // J. Am. Acad. Dermatol. 2020. Vol. 82. N. 6. P. 1501–1510. DOI: https://doi.org/10.1016/j.jaad.2020.01.077. Epub 2020 Feb 7. PMID: 32035944.

Two A.M., Wu W., Gallo R.L., Hata T.R. Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors // J. Am. Acad. Dermatol. 2015. Vol. 72. N. 5. P. 749–758. DOI: https://doi.org/10.1016/j.jaad.2014.08.028. PMID: 25890455.

US Food and Drug Administration. Mirvaso (brimonidine) gel, 0.33%, for topical use: prescribing information. 2013. URL: https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204708lbl.pdf (дата обращения: 16.08.2023).

URL: https://eyewiki.org/Morbihan_Disease

Van Zuuren E.J., Arents B.W.M., van der Linden M.M.D. et al. Rosacea: new concepts in classification and treatment // Am. J. Clin. Dermatol. 2021. Vol. 22. N. 4. P. 457–465. DOI: https://doi.org/10.1007/s40257-021-00595-7. Epub 2021 Mar 23. PMID: 33759078; PMCID: PMC8200341.

Van Zuuren E.J., Fedorowicz Z., Tan J. et al. Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments // Br. J. Dermatol. 2019. Vol. 181. N. 1. P. 65–79. DOI: https://doi.org/10.1111/bjd.17590. Epub 2019 Mar 10. PMID: 30585305; PMCID: PMC6850438.

Veerkamp P., Mousdicas N., Bednarek R. Rosacea fulminans precipitated by acute stress: a case report describing an integrative approach for a patient reluctant to use isotretinoin // Integr. Med. (Encinitas). 2016. Vol. 15. N. 6. P. 32–35. PMID: 28223895; PMCID: PMC5312834.

Veien N.K., Stahl D., Brodthagen H. Granulomatous rosacea treated with tetracycline // Dermatologica. 1981. Vol. 163. N. 3. P. 267–269. DOI: https://doi.org/10.1159/000250171. PMID: 6456953.

Veraldi S., Persico M.C., Francia C. Morbihan syndrome // Indian Dermatol. Online J. 2013. Vol. 4. N. 2. P. 122–124. DOI: https://doi.org/10.4103/2229-5178.110639. PMID: 23741671; PMCID: PMC3673378.

Vidigal M.R., Kakihara C.T., Gatti T.R. et al. Gnatophyma: a rare variant of phyma // Clin. Exp. Dermatol. 2008. Vol. 33. N. 6. P. 743–744. DOI: https://doi.org/10.1111/j.1365-2230.2008.02862.x. Epub 2008 Jun 25. PMID: 18616722.

Voth H., Wenzel J., Bieber T., Landsberg J. Phymatous transformation of facial cutaneous vascular malformations: clues to phyma pathogenesis // JAMA Dermatol. 2013. Vol. 149. N. 3. P. 368–369. DOI: https://doi.org/10.1001/jamadermatol.2013.1213. PMID: 23552898.

Walsh R.K., Endicott A.A., Shinkai K. Diagnosis and treatment of rosacea fulminans: a comprehensive review // Am. J. Clin. Dermatol. 2018. Vol. 19. N. 1. P. 79–86. DOI: https://doi.org/10.1007/s40257-017-0310-0. PMID: 28656562.

Wilkin J., Dahl M., Detmar M. et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea // J. Am. Acad. Dermatol. 2002. Vol. 46. N. 4. P. 584–587. DOI: https://doi.org/10.1067/mjd.2002.120625. PMID: 11907512.

Wohlrab J., Lueftl M., Marsch W.C. Persistent erythema and edema of the midthird and upper aspect of the face (Morbus Morbihan): evidence of hidden immunologic contact urticaria and impaired lymphatic drainage // J. Am. Acad. Dermatol. 2005. Vol. 52. N. 4. P. 595–602. DOI: https://doi.org/10.1016/j.jaad.2004.08.061. PMID: 15793508.

Woźniak E., Owczarczyk-Saczonek A., Lange M. et al. The Role of mast cells in the induction and maintenance of inflammation in selected skin diseases // Int. J. Mol. Sci. 2023. Vol. 24. N. 8. Article ID 7021. DOI: https://doi.org/10.3390/ijms24087021. PMID: 37108184; PMCID: PMC10139379.

Yamasaki K., Di Nardo A., Bardan A. et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea // Nat. Med. 2007. Vol. 13. N. 8. P. 975–980. DOI: https://doi.org/10.1038/nm1616. Epub 2007 Aug 5. PMID: 17676051.

Yang J.H., Cho S.I., Suh D.H. Granulomatous rosacea in Korean patients: diagnosis based on combining clinical and histological findings // Dermatology. 2021. Vol. 237. N. 6. P. 907–911. DOI: https://doi.org/10.1159/000510656. Epub 2020 Oct 22. PMID: 33091912.

Yeh M.C., Tsai J., Huang Y.C., Wang H.H. Topical Metronidazole versus ivermectin for low-density demodex rosacea: a rater-blinded, randomized, split-face trial // Acta Derm. Venereol. 2022. Vol. 102. Article ID adv00811. DOI: https://doi.org/10.2340/actadv.v102.4391. PMID: 36317858; PMCID: PMC9811289.

Yvon C., Mudhar H.S., Fayers T. et al. Morbihan syndrome, a UK case series // Ophthalmic Plast. Reconstr. Surg. 2020. Vol. 36. N. 5. P. 438–443. DOI: https://doi.org/10.1097/IOP.0000000000001589. PMID: 31990896.

Zip C. The role of skin care in optimizing treatment of acne and rosacea // Skin Therapy Lett. 2017. Vol. 22. N. 3. P. 5–7. PMID: 28492949.